6 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
= venous thromboembolism ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... Anticoagulation #Management #Hematology ... #Oncology
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... #Management #VTE ... #DVT #Algorithm ... #Venous #Thromboembolism ... #Treatment #Hematology
Approach to the Hypercoagulable State
Arterial thromboembolism
→ Cardiac rhythm monitoring, Echocardiogram, Vascular imaging
→ Test for APS, particularly
history of prior venous ... Age-appropriate cancer ... Hypercoagulable #Workup #hematology ... #diagnosis #algorithm ... #hematology #VTE
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
and incidental DVT ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... Anticoagulation #Management #Hematology ... #Oncology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
of Therapy for Venous ... Thromboembolic ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... #hematology #length
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Thromboembolism ... Treatment Algorithm ... therapy - Second VTE ... #management #hematology